Literature DB >> 9393782

Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

S Ghaem-Maghami1, R L Bailey, D C Mabey, P E Hay, O S Mahdi, H M Joof, H C Whittle, M E Ward, D J Lewis.   

Abstract

The circulating B-cell responses to Chlamydia trachomatis of 60 children and 34 adults in The Gambia were characterized in a cross-sectional study of different grades of trachoma, using the enzyme-linked immunospot (ELISPOT) assay. Antibody-secreting cells (ASCs) specific to chlamydial major outer membrane protein (MOMP), heat shock protein 60, and whole elementary bodies were detected in children with no evidence of ocular disease, and the immunoglobulin (IgA) response was significantly increased in those with follicular trachoma. In marked contrast, children with the most intense ocular inflammation paradoxically had an almost completely absent B-cell response of all isotypes and to all chlamydial antigens, but with normal serum IgG and IgA responses, which was even lower than in the group with no ocular inflammation. Adults with or without evidence of trachomatous scarring had equivalent numbers of circulating B cells, principally IgA, to all chlamydial antigens. Plasmablasts secreting antibodies to MOMP were present in the urine of children in the absence of urogenital infection detectable by PCR, and relative numbers were 8 to 25 times higher than in blood, suggesting site-specific homing within a common mucosal immune system. These results suggest that ELISPOT assay of ongoing B-cell responses detects suppression of chlamydia-specific IgA ASCs during the proinflammatory response to ocular chlamydial infection seen in intense trachoma, which may play a role in tissue damage leading to trachomatous scarring.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393782      PMCID: PMC175715          DOI: 10.1128/iai.65.12.4958-4964.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 2.  Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.

Authors:  R P Morrison
Journal:  Semin Immunol       Date:  1991-01       Impact factor: 11.130

3.  The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit.

Authors:  D J Lewis; P Novotny; G Dougan; G E Griffin
Journal:  Eur J Immunol       Date:  1991-09       Impact factor: 5.532

4.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit.

Authors:  L R Castello-Branco; G E Griffin; T A Poulton; G Dougan; D J Lewis
Journal:  Vaccine       Date:  1994-01       Impact factor: 3.641

Review 6.  Lymphocyte life-span and memory.

Authors:  J Sprent; D F Tough
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

Review 7.  Chlamydia and Reiter's syndrome (reactive arthritis).

Authors:  M U Rahman; A P Hudson; H R Schumacher
Journal:  Rheum Dis Clin North Am       Date:  1992-02       Impact factor: 2.670

Review 8.  Immunobiology of IgA.

Authors:  J Mestecky
Journal:  Am J Kidney Dis       Date:  1988-11       Impact factor: 8.860

9.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities.

Authors:  R L Bailey; T J Hampton; L J Hayes; M E Ward; H C Whittle; D C Mabey
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  5 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.

Authors:  Matthew J Burton; Athumani Ramadhani; Helen A Weiss; Victor Hu; Patrick Massae; Sarah E Burr; Wahida Shangali; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma.

Authors:  Troy Skwor; Ram Prasad Kandel; Sunniya Basravi; Aslam Khan; Bassant Sharma; Deborah Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

4.  Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

Authors:  S Ghaem-Maghami; G Ratti; M Ghaem-Maghami; M Comanducci; P E Hay; R L Bailey; D C W Mabey; H C Whittle; M E Ward; D J M Lewis
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

5.  Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.

Authors:  Deborah Dean; Ram P Kandel; Him K Adhikari; Tracey Hessel
Journal:  PLoS Med       Date:  2008-01-03       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.